BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.
| CFO: |
Duncan Kennedy |
| Non-Executive Director: |
William James (Jim) O'Shea, Ian F R Much, Richard Wohanka , Gregory Barrett , Susan (Sue) Foden, Anne Thorburn |
| Senior Independent Director: |
Giles Kerr |
| Senior Independent Non-Executive Director: |
Graham Hetherington |
| Address: |
5 Fleet Place, London |
| Phone: |
+44 (0)20 7575 0000 |
| Fax: |
+44 (0)20 7575 0010 |
| Website: |
http://www.btgplc.com |
| Email: |
|